Press Releases

TORONTO, Sept. 19, 2019 /PRNewswire/ - Baylis Medical announced today key activities that will be featured at Transcatheter Cardiovascular Therapeutics (TCT) 2019, the Cardiovascular Research Foundation's 31st annual conference and premier interventional cardiovascular medicine educational meeting, in San Francisco, CA from

SAN JOSE, Calif., Sept. 19, 2019 /PRNewswire/ -- Seabright Healthcare recently completed a project at El Camino Health hospitals focused on reducing the cost of spinal implants and supplies. Using Seabright's analytics and proprietary algorithms, El Camino Health was able to bring together its internal team, independent physician partners, and suppliers to achieve

MINNEAPOLIS, Sept. 19, 2019 /PRNewswire/ -- Excelera® today announced the company has established a systematic process for measuring medication adherence among patients taking specialty medications in the Excelera Network, a nationwide network of health systems with integrated specialty pharmacies. Initially presented as a

SUZHOU, China, Sept. 19, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, metabolic and other major diseases, announced today that the results of efficacy and safety of IBI305 (bevacizumab biosimilar) versus bevacizum

OXFORD, England, Sept. 19, 2019 /PRNewswire/ -- Oxford Nanopore and Caribou Biosciences, Inc. have entered into a non-exclusive license agreement under which Caribou has granted Oxford Nanopore a worldwide, non-exclusive license under foundational CRISPR-Cas9 intellectual property controlled by Caribou for nanopore sequencing. "The Cas9 technique will enable u

BLUE BELL, Pa. and ASHBURN, Va., Sept. 19, 2019 /PRNewswire/ -- Medical Optometry America (MOA) is excited to announce that it has signed an agreement with Associates in Eyecare – Optometrists (AIE) under which AIE will become the nation's first group of independent optometric practices to adopt the MOA Brand.

BASEL, Switzerland, Sept. 19, 2019 /PRNewswire/ --New interim data from SPR1NT study supports critical importance of early intervention in pre-symptomatic SMA patients, leading to age‑appropriate major milestone gain Updated results from global STR1VE study demonstrate that Zolgensma® (on

SAN ANTONIO, Sept. 19, 2019 /PRNewswire/ -- An article recently published in Radiology highlights the groundbreaking use of a new imaging technology introduced by Seno Medical Instruments, Inc.® (Seno Medical) to diagnose breast cancer. The technology may offer physicians a new, non-invasive tool to not only better differentiate be

SAN DIEGO, Sept. 18, 2019 /PRNewswire/ -- Debut Biotechnology, a startup located in San Diego, California, has exclusively licensed two inventions from the University of California, Irvine (UCI) that will allow continuous manufacturing in the pharmaceutical, alcoholic beverage, and cannabinoid industries.

OLDWICK, N.J., Sept. 18, 2019 /PRNewswire/ -- Provention Bio, Inc., (Nasdaq: PRVB), a clinical-stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced the pricing of its previously announced underwritten registered public offering of 5,000,000 shares of its common stock, offered at a public offering price of